MP is an investigator for Bayer, Bristol-Myers Squibb, Eisai, Ipsen, Lilly, and Roche; received speaker honoraria from Bayer, Bristol-Myers Squibb, Eisai, Lilly, Merck Sharp & Dohme, and Roche; is a consultant for AstraZeneca, Bayer, Bristol-Myers Squibb, Eisai, Ipsen, Lilly, Merck Sharp & Dohme, and Roche; and received travel support from Bayer, Bristol-Myers Squibb, and Roche. DJP received lecture fees from ViiV Healthcare, Bayer Healthcare, Bristol-Myers Squibb, Roche, Eisai, and Falk Foundation; travel expenses from Bristol-Myers Squibb, Roche, and Bayer Healthcare; consulting fees for Mina Therapeutics, Eisai, Roche, Avamune, DaVolterra, Mursla, H3 Biomedicine, Ipsen, Exact Sciences, and AstraZeneca; and research funding (to institution) from Merck Sharpe & Dohme, GlaxoSmithKline, and Bristol-Myers Squibb.